Other
Remainder of Fiscal Year 2024
Amgen Remainder of Fiscal Year 2024 increased by 200.0% to $2.70B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.9%, from $3.10B to $2.70B.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2020
Last reportedQ1 2026
Metric ID:
remainder_2024Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.20B | $600.00M | $1.90B | $1.30B | $600.00M | $2.10B | $1.40B | $700.00M | $3.60B | $2.40B | $1.20B | $3.10B | $2.00B | $900.00M | $2.70B |
| QoQ Change | — | -50.0% | +216.7% | -31.6% | -53.8% | +250.0% | -33.3% | -50.0% | +414.3% | -33.3% | -50.0% | +158.3% | -35.5% | -55.0% | +200.0% |
| YoY Change | — | — | — | +8.3% | +0.0% | +10.5% | +7.7% | +16.7% | +71.4% | +71.4% | +71.4% | -13.9% | -16.7% | -25.0% | -12.9% |
Range$600.00M – $3.60B
CAGR+26.1%
Avg YoY Growth+15.8%
Median YoY Growth+8.0%
Remainder of Fiscal Year 2024 at Other Companies
Frequently Asked Questions
- What is Amgen's remainder of fiscal year 2024?
- Amgen (AMGN) reported remainder of fiscal year 2024 of $2.70B in Q1 2026.
- How has Amgen's remainder of fiscal year 2024 changed year-over-year?
- Amgen's remainder of fiscal year 2024 decreased by 12.9% year-over-year, from $3.10B to $2.70B.